• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

COHR offering to raise $50 million

Article

Independent service organization COHR of Chatsworth, CA, has fileda registration statement with the Securities and Exchange Commissionfor a secondary stock offering of 1.9 million shares. At COHR'scurrent stock price of $26.50 a share, the offering would

Independent service organization COHR of Chatsworth, CA, has fileda registration statement with the Securities and Exchange Commissionfor a secondary stock offering of 1.9 million shares. At COHR'scurrent stock price of $26.50 a share, the offering would raiseover $50 million. The company will offer 1.5 million shares ofstock, while 400,000 shares will be sold by existing stockholders.

COHR did not indicate what it planned to use the money for,but the ISO has been growing rapidly in the past two years, primarilythrough acquisition. It bought MRI service company Vision MedicalServices in May (SCAN 5/22/96). COHR chief executive Paul Choprahas stated that the company is planning further acquisitions asthe ISO industry consolidates.

In other news, COHR last month moved to a new office in Chatsworth,from its previous headquarters in Los Angeles. The new facilityincludes 80,000 square feet of office space and enables COHR tounify its three main operating divisions for the first time.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.